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Recent studies have provided evidence that mitochondrial
dysfunction and endoplasmic reticulum (ER) stress are
major pathogenic factors for diabetes and its complications.
Mitochondria are the most important source of the chem-
ical energy required by cells. Regulation of the role that
mitochondria play in the metabolism of glucose and fatty
acids, the primary fuels used by cells to produce ATP, has
been the subject of intensive research for several decades.
In spite of this, much remains to be learned about tissue-
speciﬁc fuel selection and the pathogenesis of diabetes and
its complications. Mitochondria also play an important role
in the generation of reactive oxygen species (ROS) and
cell apoptosis. The ER is a major subcellular compartment
involved in calcium homeostasis, lipid synthesis, and protein
folding and maturation. Various factors that interfere with
ER function lead to accumulation of unfolded proteins.
This triggers downstream signaling pathways, which is called
the unfolded protein response (UPR). Although this is
an adaptive mechanism to resolve ER stress, chronic UPR
activation may lead to cell injury. Cellular homeostasis
also depends upon the functional relationship between
mitochondria and the ER. Propagation of calcium signaling
fromERtomitochondriaisinvolvedinbothATPproduction
and cell death. On the other hand, the ER requires ATP to
functionproperly,whichmaymakeitthebestsiteforsensing
metabolic stress.
In this special issue of the journal we have assembled
several invited reviews, from well-recognized investigators,
on the roles of mitochondrial dysfunction and ER stress in
the pathogenesis of diabetes and its complications. Some
papers also deal with important issues like mitochondrial
biogenesis, mitochondrial fusion/ﬁssion, and autophagy in
the diabetic state.
Dr. A. Naudi et al. reviewed the mechanism of cellular
dysfunction in response to mitochondrial oxidative stress.
Increases in plasma glucose and free fatty acid (FFA) cause
mitochondrial overproduction of ROS. This leads to several
maladaptive responses including blockade of glycolysis and
accumulation of upstream glycolytic metabolites, PARP
activation and consequent increases in the production of
inﬂammatory mediators, and protein oxidative damage.
They also suggested the use of antioxidants, uncouplers, or
PARP inhibitors for the prevention or reversal of diabetic
complications.
Dr. Z. A. Ma et al. discussed the molecular mechanism of
mitochondrial dysfunction-induced cell injury. In pancreatic
beta cells, mitochondrial ROS produced by metabolic stress
activates UCP2, which leads to proton leak across the mito-
chondrial inner membrane. This reduces beta cell synthesis
of ATP and reduces glucose-stimulated insulin secretion.
In addition, ROS oxidizes polyunsaturated fatty acids in
mitochondrial membrane phospholipids (cardiolipin), and
this impairs membrane integrity and leads to cytochrome c
release into the cytosol and apoptosis. Group VIA phospho-
lipase A2 (iPLA2beta) appears to provide a mechanism for
repairing mitochondrial phospholipid damage. The authors
suggestedthatinterventionsthatattenuatetheadverseeﬀects
of ROS on beta-cell mitochondrial phospholipids may
represent a means for preventing the development of type 2
diabetes.2 Experimental Diabetes Research
Dr. B. Ponugoti et al. reviewed the role of the FOXO
family of forkhead transcription factors in the regulation of
cellular oxidative stress response pathways. FOXO proteins
are known to play an important role in protection of cells
against oxidative stress. However, in response to certain ROS
levels, FOXO proteins switch from prosurvival to proapop-
totic signaling, resulting in cell death. In the diabetic state,
the induction of FOXO by hyperglycemia plays an important
role in the generation of proinﬂammatory cytokines. On the
otherhand,insulinsignalinginactivatesFOXO1.Theauthors
suggested that activated FOXO1 disrupts the mitochondrial
electron transport chain, negatively aﬀecting fatty acid
oxidation.
Dr. A.-M. Joseph et al. reviewed skeletal muscle mito-
chondrial metabolism with special emphasis on mito-
chondrial biogenesis, mitochondrial fusion/ﬁssion, and
autophagy. Mitochondrial biogenesis is induced by numer-
ous physiological, environmental, and pharmacological
stimuli and is regulated by various factors including PGC-1,
NRF 1/2, and SIRT1–7. In the diabetic state, these processes
become deregulated and the ability of the cell to respond
to environmental changes is diminished. The potential
to stimulate mitochondrial biogenesis through physiolog-
ical interventions such as exercise, caloric restriction, or
pharmacological mimetics of mitochondrial biogenesis can
be promising in improving insulin sensitivity. The paper
also described mitochondrial dynamics (fusion/ﬁssion) and
autophagy. Levels of the fusion proteins Mfn2 and OPA1 are
reduced in skeletal muscles of diabetic patients, suggesting
mitochondrial fusion is an important signaling event for
mitochondrial biogenesis in muscle.
Dr. S. H. Back et al., Dr. U. Karunakaran et al., Dr.
B. Basha et al., and Dr. J. Xu et al. separately reviewed
the roles of ER stress in the pathogenesis of beta-cell
failure, endothelial dysfunction, and diabetic cardiomyopa-
thy, respectively. ER plays a central role in protein folding
and in quality control of newly synthesized proteins. The
ER also serves as an essential site for synthesis of lipids
and for high-capacity buﬀering of intracellular calcium.
Increased demand or decreased ability to fold proteins in
the ER leads to accumulation of unfolded proteins in the
ER, a state called “ER stress.” In this state, a series of
compensatory mechanisms are induced, collectively termed
UPR,thatincludeinhibitionofproteintranslation,increased
expression of ER chaperones, ER-associated degradation,
and cell apoptosis. Although this is an adaptive mechanism
to resolve ER stress, chronic UPR activation may lead to
cell injury. In the diabetic state, high plasma glucose and
FFA levels are well known to cause cellular dysfunction
and injury, which is called “glucotoxicity,” “lipotoxicity,”
and “glucolipotoxicity” when the two are combined. These
metabolic stresses are known to induce ER stress and UPR.
Dr. Y. Tanaka et al. reviewed the role of autophagy in
the pathogenesis of diabetic nephropathy. Autophagy is a
major catabolic pathway involved in degrading and recy-
cling macromolecules and damaged organelles to maintain
intracellular homeostasis. This dynamic process involves
membrane formation and fusion and includes autophago-
some formation, autophagosome-lysosome fusion, and the
degradation of intra-autophagosomal contents by lysosomal
hydrolases. The authors summarized recent studies showing
that autophagy in podocytes and renal tubular epithelial
cells plays a renoprotective function under several pathologic
conditions.
Finally, Dr. J. Leem and Dr. E. H. Koh reviewed the
functional relationship between mitochondria and the ER.
Recentstudiesusingelectrontomographydemonstratedthat
the outer mitochondrial membrane and the ER are joined
by tethers, enabling ER proteins to associate directly with
proteins and lipids of the outer mitochondrial membrane.
Many papers to date have shown that ER stress induces
mitochondrial dysfunction to cause cell apoptosis. In addi-
tion, recent lines of evidence suggest that the reverse is also
happening; mitochondrial dysfunction induces ER stress to
decrease adiponectin synthesis in adipocytes and to cause
hepatic insulin resistance. Thus, it appears that bidirectional
communications exist between these two organelles. Future
studies are needed to carefully dissect the interactions
between mitochondria and ER.
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